510(k) Report

510(k) · Cleared

Cleared

Access Thyroglobulin

K240927510(k) TraditionalCleared Jun 28, 202485-day reviewClass II21 CFR 866.6010

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Beckman Coulter, Inc. · MSW System, Test, Thyroglobulin

Cleared on Jun 28, 2024 as substantially equivalent to K220972 (Beckman Coulter, Inc., 2023) after an 85-day review. Its family tree reaches back 2 generations to 2000.

Decided
Jun 28, 2024
Review
85 days
Class
Class II
Product code
MSW
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K002905 (2000). No later device cites it as a predicate yet.

  1. Root · 2 generations backK002905 Access Thyroglobulin Reagents on the Access AnalyzerBeckman Coulter, Inc. · 2000 · Recalled
  2. 1 generation backK220972 Access ThyroglobulinBeckman Coulter, Inc. · 2023
  3. This deviceK240927 Access ThyroglobulinBeckman Coulter, Inc. · 2024
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K002905Access Thyroglobulin Reagents on the Access AnalyzerBeckman Coulter, Inc.20004
−1K220972Access ThyroglobulinBeckman Coulter, Inc.2023—
0 (this device)K240927Access ThyroglobulinBeckman Coulter, Inc.2024—
FIG. 1 — Lineage of K240927, 2000–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MSW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MSW device

  1. #1 K220972 Access Thyroglobulinscore 12.0 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K220972Access Thyroglobulin
Summary page 5
…= Page 5 === Predicate Device: The modified Access Thyroglobulin assay claims substantial equivalence to previously cleared Access Thyroglobulin assay, FDA 510(k) Number K220972, cleared September 15, 2023. Device Description: The Access Thyroglobulin assay consists of the reagent pack and calibrators. O…
Beckman Coulter, Inc.2023—

Also cleared against K220972: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 24 years and passes through 1 company; a new generation was cleared every 22.9 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • 1 other device also cites its predicate K220972.

How does its category compare?

All MSW devices

MSW System, Test, Thyroglobulin: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · MSW

1in 2025

2023: 22024: 22025: 1
2007high 2 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MSW

Too few MSW 510(k)s in any year since 2007 to give a median.

Recalls per year · MSW

1in 2023

2010: 12022: 22023: 1
2007high 2 (2022) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MSW

3in 2025

2012: 22013: 22015: 12016: 12017: 32018: 52019: 22022: 572023: 42024: 32025: 3
2007high 57 (2022) · low 0 (2007)2025

MAUDE reports naming product code MSW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—10
20110—00
20120—02
20130—02
20140—00
20150—01
20160—01
20170—03
20180—05
20190—02
20200—00
20210—00
20220—257
20232—14
20242—03
20251—03
20260—0—

What is it indicated for?

Access Thyroglobulin assay is a paramagnetic particle, chemiluminescent immunoassay for the quantitative determination of thyroglobulin levels in human serum and plasma using the Access Immunoassay Systems. This device is intended to aid in monitoring for the presence of persistent or recurrent/metastatic disease in patients who have differentiated thyroid cancer (DTC) and have had thyroid surgery (with or without ablative therapy), and who lack serum thyroglobulin antibodies.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K240927: Access Thyroglobulin.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K240927

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026